Clinical Trials Directory

Trials / Unknown

UnknownNCT00345566

Effect of Protein Composition on Gastric Emptying

Effect of the Protein Composition on the Gastric Emptying Rate in Children With Cerebral Paresis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (planned)
Sponsor
Ullevaal University Hospital · Academic / Other
Sex
All
Age
1 Year – 16 Years
Healthy volunteers
Not accepted

Summary

The protein composition of nutrition may affect the rate of gastric emptying and gastric fysiology. This is espesially important in children with neurologic impariment, who commonly rely on tube feedings, have feeding problems, nausea, vomiting, gastroesophageal reflux and delayed gastric emptying. We aim to find out whether 4 different protein sources affect the rate of gastric emptying and electrofysiology in this group of children.

Detailed description

Several factors in nutrition are known to affect gastric emptying rate, such as energy content, temperature, viscosity etc. In infants the protein composition affects gastric emptying. Children with cerebral pasly commonly have foregut dysmotility - with nausea, vomiting, feeding intolerance and gastroesophageal reflux. Tube feedings, usually based on cows milk are commonly used. Our hypothesis is that the source and thus protein composition of feeding affects gastric emptying rate and electrofysiology. Using four different tube feedings, standardized for content of fat, glucose and calories, we will measure gastric emptying rate using C13 octanoic acid as well as electrogastrography will be recorded. The protein modules are derived from casein, whey/casein mixture, hydrolyzed whey and aminoacids. Children with cerebral paresis and gastrostomy will be included. Each serves as his / her own control. The primary endpoint is gastric emptying rate, the secondary endpoint electrogastrography.

Conditions

Interventions

TypeNameDescription
PROCEDURENutrition composition

Timeline

Start date
2006-08-01
Completion
2007-12-01
First posted
2006-06-28
Last updated
2006-06-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00345566. Inclusion in this directory is not an endorsement.